Stock Information
Beam Therapeutics Inc (BEAM)
Ticker Symbol: BEAM
Exchange: NASDAQ
Sector: Biotechnology
Market Cap: $2,502.37 mil
Piotroski score: 4
PE Ratio: N/A
EPS (TTM): -0.9704
Revenue (TTM): $1.36 M
Dividend Yield: N/A%
ROE: -7.31%
Latest News
-
Beam Therapeutics Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026
Thu, May 7, 2026 11:41 AM
-
Wave Life Sciences: Good Platform, Mixed Clinical Trial Data, Hold
Thu, May 7, 2026 11:02 AM
-
Beam Therapeutics Q1 EPS $(0.91) Beats $(1.09) Estimate, Sales $31.738M Beat $10.977M Estimate
Thu, May 7, 2026 7:24 AM
Key Financials
Financial data not available
